Aurora Cannabis Inc. Prepares for Shareholder Meeting with Management Information Circular Announcement

Aurora Cannabis Inc. Announces Management Information Circular for Shareholders

On July 9, 2025, Aurora Cannabis Inc. unveiled the filing and mailing of its Management Information Circular in relation to the upcoming Annual General and Special Meeting of Shareholders. As a front-runner in the field of medical cannabis based in Canada, Aurora's recent announcement emphasizes its commitment to transparency and shareholder engagement.

The Management Information Circular has been made accessible on both the company's website and its profile on SEDAR+. Shareholders can view the circular by visiting Aurora's investor relations page. The materials have been sent out to shareholders recorded as of June 16, 2025, emphasizing the critical nature of the upcoming meeting to the company's governance.

In a message from CEO Miguel Martin and CFO Simona King, available on the company's investor site, they reflect on the achievements of fiscal 2025 and discuss future prospects for Aurora. This presentation is part of the company’s initiative to keep its stakeholders informed about strategic decisions and operational developments.

Meeting Details

The virtual shareholder meeting is scheduled for Friday, August 8, 2025. Starting at 1:00 p.m. Eastern Time (ET) / 11:00 a.m. Mountain Time (MT), the meeting will be hosted via live webcast at this link. The decision to conduct the meeting online aims to provide an equitable platform for all shareholders, regardless of their geographic location or number of shares held.

All shareholders are strongly encouraged to review the circular thoroughly and cast their votes promptly. The deadline for submitting votes is August 6, 2025, at 1:00 p.m. ET. Close collaboration with shareholders is paramount, and Aurora’s board of directors recommends supporting all director nominees and other meeting resolutions.

Voting Assistance

Aurora recognizes the importance of each vote and is actively facilitating the voting process. Any shareholders who have inquiries or require assistance are advised to reach out to Aurora's strategic advisor and proxy solicitation agent, Laurel Hill Advisory Group. They can be contacted by telephone at 1-877-452-7184 or via email at email@laurelhill.com.

About Aurora

Aurora Cannabis Inc. is dedicated to pioneering the cannabis industry on a global scale. Headquartered in Edmonton, Alberta, the company caters to both the medical and consumer cannabis markets across regions including Canada, Europe, Australia, and New Zealand. Their diverse portfolio includes various adult-use and medical cannabis brands such as Drift, San Rafael '71, and MedReleaf, among others. Aurora’s mission is to enhance lives through innovative and high-quality cannabis products.

The company trades on the NASDAQ and TSX under the ticker symbol "ACB". By embracing a forward-looking approach, Aurora aims to navigate the dynamic landscape of the cannabis market while ensuring that shareholders are well-informed and engaged in the company’s trajectory.

In line with regulatory requirements, the company has also issued statements regarding forward-looking information. These statements aim to provide insights into potential developments while cautioning stakeholders to consider associated risks and uncertainties. Aurora emphasizes that the information shared should encourage active engagement and informed decision-making among its investors.